Table 2.

Gender, pre- and post-operative acid output measurements and durations of disease, cure and drug withdrawal in 16 patients who were able to discontinue all antisecretory therapy successfully

		Pre-operative				At withdrawal
Patient	Gender	Disease duration (years)	BAO (mmol/h)	MAO (mmol/h)	BAO/MAO ratio	Time after surgery (months)	BAO (mmol/h)	MAO (mmol/h)	BAO/MAO ratio	Time off all medicine (months)
1	F	0.8	30	75	0.4	24	1	34	<0.1	29†
2	F	4.5	30	33	0.9	104	1	27	<0.1	105
3	M	10	24	58	0.4	17	13	48	0.2	11
4*	M	15.5	8	11	0.7	69	1	5	0.2	75
5*	M	17.5	10	19	0.5	80	1	4	0.3	109
6	M	14.9	2	4	0.5	46	0	2	0	70
7	F	5.8	44	44	1.0	21	3	30	0.1	11
8	F	2.6	25	31	0.8	55	6	16	0.4	12‡
9	F	6.3	15	50	0.3	16	8	50	0.2	10
10	M	9.9	25	41	0.6	41	5	24	0.2	10
11	F	5.6	44	54	0.8	4	3	51	<0.1	10
12	F	3.1	50	50	1.0	6	6	47	0.1	11
13	M	14.9	60	65	0.9	59	4	41	0.1	6
14	M	3.0	43	71	0.6	5	6	36	0.2	7
15	F	3.3	19	58	0.3	58	9	35	0.3	2
16	M	8.5	50	58	0.9	61	17	23	0.7	12†
Mean ± S.E.M.		7.9 ± 1.3	30 ± 4	45 ± 5	0.66 ± 0.06	42 ± 7	5 ± 1	30 ± 4	0.2 ± 0.04	31 ± 9
Range		0.8 ± 17.5	2–60	4–75	0.3–1.0	4–104	0–17	2–58	0–0.7	2–109

^*Previous partial gastrectomy.

^†Developed evidence of gastrinoma recurrence during follow-up

^‡Restarted medication after the diagnosis of a gastric ulcer.